Han Liang

62.9k total citations · 2 hit papers
199 papers, 9.3k citations indexed

About

Han Liang is a scholar working on Molecular Biology, Cancer Research and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Han Liang has authored 199 papers receiving a total of 9.3k indexed citations (citations by other indexed papers that have themselves been cited), including 121 papers in Molecular Biology, 43 papers in Cancer Research and 35 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Han Liang's work include RNA modifications and cancer (31 papers), Gastric Cancer Management and Outcomes (23 papers) and Bioinformatics and Genomic Networks (22 papers). Han Liang is often cited by papers focused on RNA modifications and cancer (31 papers), Gastric Cancer Management and Outcomes (23 papers) and Bioinformatics and Genomic Networks (22 papers). Han Liang collaborates with scholars based in United States, China and South Korea. Han Liang's co-authors include Leng Han, Jun Li, Yuan Yuan, Gordon B. Mills, Yumeng Wang, Wen‐Hsiung Li, Li Ma, Yutong Sun, Mien‐Chie Hung and Laura F. Landweber and has published in prestigious journals such as Nature, Proceedings of the National Academy of Sciences and The Lancet.

In The Last Decade

Han Liang

187 papers receiving 9.2k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Clonal evolution in breast cancer revealed by single nucleus genome sequencing

2014 711 citations Han Liang et al. profile →
Long noncoding RNA MALAT1 suppresses breast cancer metastasis

2018 546 citations Jongchan Kim, Yumeng Wang et al. profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Han Liang United States	46	6.5k	3.9k	1.8k	1.1k	633	199	9.3k
Feng Jiang United States	50	5.7k 0.9×	3.9k 1.0×	1.8k 1.0×	1.2k 1.1×	456 0.7×	134	8.4k
Francesca M. Buffa United Kingdom	46	6.1k 0.9×	5.1k 1.3×	1.8k 1.0×	1.1k 1.0×	439 0.7×	177	9.3k
Xian Wang China	53	7.1k 1.1×	3.6k 0.9×	1.9k 1.1×	1.2k 1.1×	585 0.9×	333	10.8k
Carl Morrison United States	45	4.2k 0.6×	2.4k 0.6×	2.3k 1.3×	1.3k 1.1×	662 1.0×	185	8.1k
Mao Mao United States	37	8.6k 1.3×	3.6k 0.9×	2.8k 1.6×	1.1k 0.9×	516 0.8×	108	13.5k
Leslie Cope United States	41	6.7k 1.0×	2.4k 0.6×	1.9k 1.1×	1.2k 1.0×	558 0.9×	132	10.3k
Ana I. Robles United States	46	5.3k 0.8×	2.6k 0.6×	2.4k 1.3×	692 0.6×	337 0.5×	93	7.5k
Aristotelis Tsirigos United States	51	6.9k 1.1×	3.0k 0.8×	1.6k 0.9×	806 0.7×	453 0.7×	146	11.0k
Charles C. Wykoff United States	50	6.5k 1.0×	5.3k 1.3×	1.1k 0.6×	1.3k 1.1×	599 0.9×	281	14.1k
Qing Li China	52	6.1k 0.9×	1.9k 0.5×	2.1k 1.2×	581 0.5×	610 1.0×	300	10.2k

Countries citing papers authored by Han Liang

Since Specialization

Citations

This map shows the geographic impact of Han Liang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Han Liang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Han Liang more than expected).

Fields of papers citing papers by Han Liang

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Han Liang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Han Liang. The network helps show where Han Liang may publish in the future.

Co-authorship network of co-authors of Han Liang

This figure shows the co-authorship network connecting the top 25 collaborators of Han Liang. A scholar is included among the top collaborators of Han Liang based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Han Liang. Han Liang is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Fan, Zhengfu, Han Liang, Suxia Luo, et al.. (2025). Intratumoral oncolytic virus OH2 injection in patients with locally advanced or metastatic sarcoma: a phase 1/2 trial. Journal for ImmunoTherapy of Cancer. 13(1). e010543–e010543. 3 indexed citations

Cai, Fenglin, et al.. (2025). Identification and validation of calcium signaling pathway-related biomarkers in T1 and T2 lymph node metastatic gastric cancer. Frontiers in Genetics. 16. 1653700–1653700.

Wan, Ting, Ting Deng, Xinxin Peng, et al.. (2025). Comprehensive Multiomics Characterization of Perineural Invasion in Cervical Cancer Reveals Diagnostic Markers, Molecular Drivers, and Therapeutic Strategies. Cancer Research. 86(6). 1514–1525.

Li, Jun, Wei Liu, Kamalika Mojumdar, et al.. (2024). A protein expression atlas on tissue samples and cell lines from cancer patients provides insights into tumor heterogeneity and dependencies. Nature Cancer. 5(10). 1579–1595. 6 indexed citations

Kim, Chiho, Xudong Wang, Zhengshuai Liu, et al.. (2024). Induced degradation of lineage-specific oncoproteins drives the therapeutic vulnerability of small cell lung cancer to PARP inhibitors. Science Advances. 10(3). eadh2579–eadh2579. 6 indexed citations

Shi, Xiaohua, Zhe Li, Xinyun Xu, et al.. (2023). HRD effects on first-line adjuvant chemotherapy and PARPi maintenance therapy in Chinese ovarian cancer patients. npj Precision Oncology. 7(1). 51–51. 7 indexed citations

Luo, Yikai & Han Liang. (2023). Single-cell dissection of tumor microenvironmental response and resistance to cancer therapy. Trends in Genetics. 39(10). 758–772. 15 indexed citations

Shen, Xin, Yikai Luo, Ying Fan, et al.. (2023). Cxxc finger protein 1 maintains homeostasis and function of intestinal group 3 innate lymphoid cells with aging. Nature Aging. 3(8). 965–981. 16 indexed citations

Bhattacharyya, Rupam, Min Jin Ha, Qingzhi Liu, et al.. (2020). Personalized Network Modeling of the Pan-Cancer Patient and Cell Line Interactome. JCO Clinical Cancer Informatics. 4(4). 399–411. 9 indexed citations

10.

Wang, Yan, Xiuchao Wang, Limei Chen, et al.. (2019). Expression of endoplasmic reticulum oxidoreductase 1-α in cholangiocarcinoma tissues and its effects on the proliferation and migration of cholangiocarcinoma cells. SHILAP Revista de lepidopterología. 2 indexed citations

11.

Shao, Xiaoyan, et al.. (2019). Sex disparities in cancer. Cancer Letters. 466. 35–38. 62 indexed citations

12.

Ye, Zhenqing, Haidong Dong, Tao Ma, et al.. (2018). Prevalent Homozygous Deletions of Type I Interferon and Defensin Genes in Human Cancers Associate with Immunotherapy Resistance. Clinical Cancer Research. 24(14). 3299–3308. 40 indexed citations

13.

Li, Jun, Rehan Akbani, Wei Zhao, et al.. (2017). Explore, Visualize, and Analyze Functional Cancer Proteomic Data Using the Cancer Proteome Atlas. Cancer Research. 77(21). e51–e54. 83 indexed citations

14.

Zhang, Qian, Zhongyuan Chen, Han Liang, et al.. (2017). Immune Microenvironment in Microsatellite-Instable Endometrial Cancers: Hereditary or Sporadic Origin Matters. Clinical Cancer Research. 23(15). 4473–4481. 92 indexed citations

15.

Kim, Jongchan, Ashley N. Siverly, Dahu Chen, et al.. (2016). Ablation of miR-10b Suppresses Oncogene-Induced Mammary Tumorigenesis and Metastasis and Reactivates Tumor-Suppressive Pathways. Cancer Research. 76(21). 6424–6435. 78 indexed citations

16.

Li, Jun, Leng Han, Paul Roebuck, et al.. (2015). TANRIC: An Interactive Open Platform to Explore the Function of lncRNAs in Cancer. Cancer Research. 75(18). 3728–3737. 407 indexed citations

17.

Yang, Jiyeon, Henrica M.J. Werner, Jie Li, et al.. (2015). Integrative Protein-Based Prognostic Model for Early-Stage Endometrioid Endometrial Cancer. Clinical Cancer Research. 22(2). 513–523. 22 indexed citations

18.

Song, Fengju, Da Yang, Ben Liu, et al.. (2013). Integrated MicroRNA Network Analyses Identify a Poor-Prognosis Subtype of Gastric Cancer Characterized by the miR-200 Family. Clinical Cancer Research. 20(4). 878–889. 94 indexed citations

19.

Kim, Yon Hui, Han Liang, Xiuping Liu, et al.. (2012). AMPKα Modulation in Cancer Progression: Multilayer Integrative Analysis of the Whole Transcriptome in Asian Gastric Cancer. Cancer Research. 72(10). 2512–2521. 79 indexed citations

20.

Cheung, Lydia W.T., Bryan T. Hennessy, Jie Li, et al.. (2011). High Frequency of PIK3R1 and PIK3R2 Mutations in Endometrial Cancer Elucidates a Novel Mechanism for Regulation of PTEN Protein Stability. Cancer Discovery. 1(2). 170–185. 352 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact